BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 6, 2015
View Archived Issues
New clamp assay detects mutational spectrum of a tumor in patient serum
Read More
Astellas review progress of first quarter of fiscal 2015
Read More
Lilly reports FFAR1 agonists
Read More
Sorrento Therapeutics licenses ex-Chinese rights to Mabtech Ltd biologics
Read More
GSK reviews progress of late-stage pipeline in second quarter 2015
Read More
Novartis patents SHP-2 inhibitors
Read More
University of California, Oakland, presents prodrugs of RTC-13
Read More
Sarmont discloses NO donors
Read More
Cadila Healthcare reports development of lipid lowering agents
Read More
BrightGene Bio-Medical Technology develops folate receptor ligands
Read More
Viewpoint Molecular Targeting and RadioMedix secure NCI grant for image guided therapy
Read More
Baxalta board rejects unsolicited acquisition proposal from Shire
Read More
New findings suggest therapeutic potential of Cirara to reduce edema in ischemic stroke
Read More
Antares Pharma starts phase III trial of subcutaneous testosterone in hypogonadism
Read More
FDA awards fast track designation to Marina Biotech's CEQ-508 for FAP
Read More
RVT-101 improves cognition and function as an adjunct therapy to donepezil
Read More
La Jolla Pharmaceutical enters exclusive license agreements for LJPC-30Sa and LJPC-30Sb
Read More
AstraZeneca licenses adenosine A2A receptor antagonist from Heptares Therapeutics
Read More
Endo sells men's health businesses to Boston Scientific and plans to reorganise Litha
Read More
ISIS Pharmaceuticals presents preliminary data for ISIS-TTRRx
Read More
Diurnal and National Institutes of Health's CRADA extended
Read More
Coferon describes bivalent Bcr-Abl tyrosine kinase inhibitors
Read More
